F11 and thrombotic disease: Similarly, recent genetic studies on coagulation factor levels47 can be harnessed to instrument the effect of modulating druggable targets for thrombotic disorders, such as FXI or FXII, which are emerging as potential targets for anticoagulant drugs48,49.